JP2008542282A5 - - Google Patents

Download PDF

Info

Publication number
JP2008542282A5
JP2008542282A5 JP2008513675A JP2008513675A JP2008542282A5 JP 2008542282 A5 JP2008542282 A5 JP 2008542282A5 JP 2008513675 A JP2008513675 A JP 2008513675A JP 2008513675 A JP2008513675 A JP 2008513675A JP 2008542282 A5 JP2008542282 A5 JP 2008542282A5
Authority
JP
Japan
Prior art keywords
alanine
free
pharmaceutical composition
edible
supplement according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008513675A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008542282A (ja
JP5336180B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/020104 external-priority patent/WO2007073398A2/en
Publication of JP2008542282A publication Critical patent/JP2008542282A/ja
Publication of JP2008542282A5 publication Critical patent/JP2008542282A5/ja
Application granted granted Critical
Publication of JP5336180B2 publication Critical patent/JP5336180B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008513675A 2005-05-23 2006-05-23 β−アラニンの徐放のための組成物及び方法 Active JP5336180B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68398505P 2005-05-23 2005-05-23
US60/683,985 2005-05-23
PCT/US2006/020104 WO2007073398A2 (en) 2005-05-23 2006-05-23 Compositions and methods for the sustained release of beta-alanine

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013127444A Division JP2013224310A (ja) 2005-05-23 2013-06-18 β−アラニンの徐放のための組成物及び方法

Publications (3)

Publication Number Publication Date
JP2008542282A JP2008542282A (ja) 2008-11-27
JP2008542282A5 true JP2008542282A5 (cg-RX-API-DMAC7.html) 2009-05-28
JP5336180B2 JP5336180B2 (ja) 2013-11-06

Family

ID=38189110

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008513675A Active JP5336180B2 (ja) 2005-05-23 2006-05-23 β−アラニンの徐放のための組成物及び方法
JP2013127444A Pending JP2013224310A (ja) 2005-05-23 2013-06-18 β−アラニンの徐放のための組成物及び方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013127444A Pending JP2013224310A (ja) 2005-05-23 2013-06-18 β−アラニンの徐放のための組成物及び方法

Country Status (8)

Country Link
US (8) US8329207B2 (cg-RX-API-DMAC7.html)
EP (2) EP3081215B9 (cg-RX-API-DMAC7.html)
JP (2) JP5336180B2 (cg-RX-API-DMAC7.html)
KR (2) KR101190791B1 (cg-RX-API-DMAC7.html)
CN (2) CN101309688B (cg-RX-API-DMAC7.html)
CA (1) CA2621365C (cg-RX-API-DMAC7.html)
DK (2) DK3081215T3 (cg-RX-API-DMAC7.html)
WO (1) WO2007073398A2 (cg-RX-API-DMAC7.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7504376B2 (en) 1996-08-12 2009-03-17 Natural Alternatives International Methods and compositions for increasing the anaerobic working capacity in tissues
US5965596A (en) 1997-08-12 1999-10-12 Harris; Roger Methods and compositions for increasing the anaerobic working capacity in tissue
EP3081215B9 (en) 2005-05-23 2020-08-19 Natural Alternatives International, Inc. Compositions and methods for the sustained release of beta-alanine
AU2007362357A1 (en) * 2007-12-12 2009-06-18 Northern Innovations And Formulations Corp. Organic salts of beta-alanine
US7956218B2 (en) * 2007-12-12 2011-06-07 Northern Innovations And Formulations Corp. Organic salts of β-alanine
JP5519945B2 (ja) * 2009-03-10 2014-06-11 株式会社ファンケル 抗不安剤
CA2674753A1 (en) * 2009-08-12 2009-11-01 Bruce W. Kneller Creatine .beta.-alaninate: a novel salt for increasing athletic performance
US9414615B2 (en) 2010-01-18 2016-08-16 PepciCo, Inc. Gel-based compositions and methods of making same
TW201201713A (en) * 2010-04-05 2012-01-16 Abbott Lab Shelf stable nutritional liquids comprising beta alanine
TW201320908A (zh) * 2011-10-13 2013-06-01 Abbott Lab 包含β－丙胺酸之營養產品
NZ717599A (en) * 2012-01-03 2017-05-26 Nestec Sa Compositions and methods for the stability of reactive amino acids in a food matrix
US8496979B1 (en) * 2012-02-02 2013-07-30 Reliv International, Inc. Caffeine-free dietary supplements for increasing energy and methods of administering the same
EP2666365A1 (en) * 2012-05-22 2013-11-27 Taminco Treatment of poultry, pigs or fish for reducing the feed conversion ratio.
ITMI20121586A1 (it) * 2012-09-24 2014-03-25 N G C Medical Spa L-carnosina per il trattamento delle miopatia congenita mitocondriale e della sindrome della fatica muscolare cronica
CN103005435B (zh) * 2012-12-13 2014-01-29 北京康比特体育科技股份有限公司 一种抗疲劳、提高速度耐力的组合物及含其制剂
HUE047629T2 (hu) 2013-01-28 2020-05-28 Lopez Hector L Eljárások ß-alanin tolerancia, farmakodinamika és hatékonyság javítására és azok alkalmazása
US20150057354A1 (en) * 2013-08-20 2015-02-26 Natural Alternatives International, Inc. Method of maintaining or improving tactical performance and cognitive function through dietary supplementation
US20180153837A1 (en) * 2015-02-27 2018-06-07 Natural Alternatives International, Inc. Methods of improving physiological responses related to post-traumatic stress disorder through dietary supplementation
WO2017053171A1 (en) * 2015-09-25 2017-03-30 Natural Alternatives International, Inc. Methods of improving physiological conditions related to pregnancy and development of offspring through dietary supplementation
CN105663081B (zh) 2015-12-30 2019-08-02 大连医诺生物股份有限公司 微囊化β-丙氨酸
WO2017142542A1 (en) * 2016-02-19 2017-08-24 Hewlett Packard Enterprise Development Lp Linear transformation accelerators
WO2018226987A1 (en) * 2017-06-07 2018-12-13 The Regents Of The University Of California Compositions for treating fungal and bacterial biofilms and methods of using the same
US12226386B2 (en) 2018-12-03 2025-02-18 The Regents Of The University Of California Compositions and methods for treating biofilms
US20220313639A1 (en) * 2019-06-28 2022-10-06 Yuki Gosei Kogyo Co., Ltd. Mitochondrial function activator
JP6749665B1 (ja) * 2019-07-18 2020-09-02 株式会社東洋新薬 経口組成物
US11850217B2 (en) 2020-05-20 2023-12-26 Advanced Food Concepts, Inc. Athletic performance enhancement composition using menthol
CN111956780A (zh) * 2020-08-28 2020-11-20 黑龙江现代物联网科技有限公司 一种用鹅肌肽制成降低人体尿酸的饮用水及其制备方法
CN113812635B (zh) * 2021-09-22 2023-12-19 大连医诺生物股份有限公司 微囊化β-丙氨酸、其制备方法及应用

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966988A (en) 1971-07-28 1976-06-29 International Flavors & Fragrances Inc. Flavoring compositions and processes utilizing dithiazine compounds
USRE30370E (en) 1971-11-04 1980-08-12 International Flavors & Fragrances Inc. Flavoring foodstuffs with a thioester
DE2519656A1 (de) 1974-05-13 1975-11-27 Sandoz Ag Neue peptide und verfahren zu ihrer herstellung
US3934036A (en) 1975-01-23 1976-01-20 Kyorin Seiyaku Kabushiki Kaisha N-benzenesulfonyl-β-alanine hydrazide useful as an immunosuppressive agent
JPS54159393A (en) 1978-06-08 1979-12-17 Ajinomoto Co Inc Polyamino acid-coated activated carbon
US4410545A (en) 1981-02-13 1983-10-18 Syntex (U.S.A.) Inc. Carbonate diester solutions of PGE-type compounds
US4328245A (en) 1981-02-13 1982-05-04 Syntex (U.S.A.) Inc. Carbonate diester solutions of PGE-type compounds
US4409239A (en) 1982-01-21 1983-10-11 Syntex (U.S.A.) Inc. Propylene glycol diester solutions of PGE-type compounds
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
JPS6016934A (ja) 1983-07-06 1985-01-28 Kaneshiro Nagai 抗腫瘍剤
IT1176983B (it) 1984-10-16 1987-08-26 Zambon Spa Dipeptidi ad attivita' farmacologica
JPS61204120A (ja) 1985-03-07 1986-09-10 Kaneshiro Nagai 免疫調節剤
US4713244A (en) 1985-08-16 1987-12-15 Bausch & Lomb Incorporated Sustained-release formulation containing an amino acid polymer with a lower alkyl (C1 -C4) polar solvent
DE3613758A1 (de) 1986-04-23 1987-10-29 Consortium Elektrochem Ind Cysteinreiche, (gamma)-glutaminsaeure- und (beta)-alanin-einheiten aufweisende peptide, verfahren zu deren herstellung und ihre verwendung
FR2609893B1 (fr) 1987-01-26 1990-03-30 Rougereau Andre Composition a base d'acides amines et de vitamines utilisable en therapeutique cancerologique
JPS6442425A (en) 1987-08-11 1989-02-14 Nippon Univ Remedy for cachexia
WO1990006102A1 (en) 1988-09-28 1990-06-14 Peptide Technology Limited Compound and method for the retardation of collagen cross-linking
JPH0395125A (ja) 1989-05-23 1991-04-19 Otsuka Pharmaceut Co Ltd カルシウム代謝改善剤
IT1240336B (it) * 1990-03-21 1993-12-07 Setra Composizioni farmaceutiche,dietetiche o veterinarie ad attivita' eumetabolica
JP2873493B2 (ja) 1990-08-09 1999-03-24 理化学研究所 血糖調節剤
JP2873497B2 (ja) 1990-09-03 1999-03-24 理化学研究所 脂質代謝調節剤
US5190775A (en) 1991-05-29 1993-03-02 Balchem Corporation Encapsulated bioactive substances
DE69231576T2 (de) 1991-09-09 2001-06-13 Kings College London, London Verwendung von Peptiden ZUR BEHANDLUNG VON KOMPLIKATIONEN UND PATHOLOGY BEI DIABETES
JPH0624976A (ja) 1992-07-10 1994-02-01 Rikagaku Kenkyusho 輸液用組成物
GB9215746D0 (en) 1992-07-24 1992-09-09 Hultman Eric A method of increasing creatine supply depot
TW333456B (en) 1992-12-07 1998-06-11 Takeda Pharm Ind Co Ltd A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
JP3213666B2 (ja) 1994-02-28 2001-10-02 治彦 末岡 クレアチン飲料の製造方法
EP0704210B1 (fr) 1994-09-30 2002-12-04 L'oreal Utilisation d'une substance agoniste d'un récepteur associé à un canal chlore dans le traitement des rides
JP3595373B2 (ja) 1995-02-20 2004-12-02 治彦 末岡 クレアチン飲料
IT1275434B (it) 1995-05-19 1997-08-07 Farmila Farma Milano Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante
CZ235798A3 (cs) 1996-01-24 1999-03-17 Aliatros Medical, A. S. Prostředek pro léčení rakoviny a způsob jeho výroby
US6274161B1 (en) * 1996-05-31 2001-08-14 The Howard Foundation Compositions containing creatine in suspension
GB9611356D0 (en) 1996-05-31 1996-08-07 Howard Alan N Improvements in or relating to compositions containing Creatine, and other ergogenic compounds
US6264970B1 (en) 1996-06-26 2001-07-24 Takeda Chemical Industries, Ltd. Sustained-release preparation
CN1268234C (zh) * 1996-08-12 2006-08-09 罗杰·哈里斯 增加组织内厌氧工作能力的方法和组合物
US7504376B2 (en) 1996-08-12 2009-03-17 Natural Alternatives International Methods and compositions for increasing the anaerobic working capacity in tissues
US5965596A (en) 1997-08-12 1999-10-12 Harris; Roger Methods and compositions for increasing the anaerobic working capacity in tissue
HUP0003393A3 (en) * 1997-05-16 2001-03-28 Amgen Inc Thousand Oaks Ustained-release delayed gels
US6019999A (en) * 1997-12-03 2000-02-01 Miller; David F. Process for making liposomal ion-exchange whey protein and products thereof
CN1132632C (zh) 1997-12-26 2003-12-31 山之内制药株式会社 缓释药物组合物
US20010041187A1 (en) * 1998-10-20 2001-11-15 Carl W Hastings Performance-enhancing dietary supplement
GB9924650D0 (en) * 1999-10-19 1999-12-22 Marathade Ltd Energy bar
WO2003024427A1 (en) * 1999-12-20 2003-03-27 Temple University Of The Commonwealth System Of Higher Education Tableted oral extended release dosage form
DE60115005T2 (de) 2000-04-19 2006-07-27 Genentech Inc., San Francisco Formulierungen mit verzögerter freisetzung enthaltend wachstumshormon
JP2002051730A (ja) 2000-08-08 2002-02-19 Nippon Meat Packers Inc スポーツ用食品
US6855727B2 (en) 2000-12-04 2005-02-15 Yaizu Suisankagaku Industry Co., Ltd. Muscular fatigue-controlling composition and method for providing muscular fatigue-controlling effect
WO2002056863A2 (en) 2000-12-29 2002-07-25 Bausch & Lomb Incorporated Sustained release drug delivery devices
JP4975943B2 (ja) * 2001-03-02 2012-07-11 ザ・ハワード・ファウンデイション クレアチンおよびクレアチニンを含有する組成物
WO2003088947A1 (en) * 2002-04-22 2003-10-30 Experimental & Applied Sciences, Inc. Food supplements containing 4-hydroxyisoleucine and creatine
US6835397B2 (en) 2002-12-23 2004-12-28 Balchem Corporation Controlled release encapsulated bioactive substances
EP3081215B9 (en) 2005-05-23 2020-08-19 Natural Alternatives International, Inc. Compositions and methods for the sustained release of beta-alanine

Similar Documents

Publication Publication Date Title
JP2008542282A5 (cg-RX-API-DMAC7.html)
CA2621365A1 (en) Compositions and methods for the sustained release of beta-alanine
ES2210282T3 (es) Agentes terapeuticos que contienen hormonas tiroideas.
ES2195798T3 (es) Formulacion para mujeres menopausicas antecedentes de la invencion.
CN1201723C (zh) 皮肤与组织护理和/或治疗制剂及其应用
US20250249016A1 (en) Immediate and controlled release appetite suppressant compositions for weight loss
CN102626225A (zh) 一种具有增加骨密度和保护关节功能的保健食品及其制备方法
CN106924106A (zh) 一种用于抑制牙菌斑和减轻牙龈炎症的牙膏
ES2640816T3 (es) Utilización de una matriz para administración oral de magnesio de liberación prolongada y composición que contiene esta matriz
JPH05502894A (ja) 放出制御性製剤及び方法
CN104983844A (zh) 具有粘膜修复功能的组合物配方及其制剂的制备过程
CA3074541C (en) Appetite suppressant compositions and methods thereof
WO2001026646A1 (en) NUTRACEUTICAL PRODUCTS CONTAINING SAMe AND DIETARY SUPPLEMENTS AND METHOD OF MANUFACTURING AND USE THEREOF
WO2006033412A1 (ja) 放射線障害軽減剤
CN108619283B (zh) 一种用于改善脂质代谢、减少内脏脂肪的组合物
EP4003275A1 (en) Cosmetic composition comprising an oral capsule containing hyaluronic acid and wheat grain oil with phytoceramides
JPS5962528A (ja) 疲労回復剤
WO2014134834A1 (zh) 组合物以及包含其的食品、该食品的制备方法
JP2004107242A (ja) 乾燥肌改善用キット
CN109432082B (zh) 一种防治化学性肝损伤的药物组合物
FR2838645A1 (fr) Nouvelles compositions synergiques de vitamines, de mineraux et d'oligo-elements pour stimuler l'elimination des lipides intracellulaires
JP2004107238A (ja) 乾燥肌改善用キット
JP2004018446A (ja) 美肌用内服剤組成物
WO2008075649A1 (ja) 発毛促進用飲食物、医薬部外品、医薬組成物ならびに発毛促進方法
CN106490623A (zh) 一种具有改善皮肤水分功能的组合物